Generating Evidence to Fight Coronavirus: the COVIDENCE study [COVID-19]
Research type
Research Study
Full title
Longitudinal population-based observational study of coronavirus disease in the UK population
IRAS ID
281648
Contact name
Adrian Martineau
Contact email
Sponsor organisation
Queen Mary University of London
Duration of Study in the UK
5 years, 0 months, 0 days
Research summary
The COVIDENCE Study is an observational longitudinal study developed in response to the outbreak of coronavirus disease (COVID-19). It aims to enrol at least 12,000 people. COVID-19 is a virus that can affect your lungs and airways and presents a major threat to human health. Currently evidence regarding risk factors, complications and long-term impacts of COVID-19 on the physical, mental and economic well-being of the UK population is limited by the lack of large population-based studies. The COVIDENCE Study is a national initiative which aims to collect data from volunteers through the use of baseline and monthly follow-up on-line questionnaires, which will allow us to shed some light on currently unanswered questions surrounding COVID-19. We will link volunteers’ self-reported data to routinely collected health data held on NHS Digital and Public Health England / Wales / Scotland / Public Health Agency (Northern Ireland) including mortality data, Hospital Episode Statistics (HES) and results of laboratory testing for SARS-CoV-2 (the virus which causes COVID-19). The COVIDENCE Study also aims to establish a platform for a future randomised controlled trial of interventions to prevent COVID-19 in the UK population. COVIDENCE participants will be asked for their consent to undergo random selection for future trials using the ’Trials within Cohorts’ design, and for use of their data as control data in the event of non-selection, without further notification.
REC name
East Midlands - Leicester South Research Ethics Committee
REC reference
20/EM/0117
Date of REC Opinion
27 Apr 2020
REC opinion
Further Information Favourable Opinion